FOR UK HEALTHCARE PROFESSIONALS ONLY
Adverse events should be reported. Reporting forms and information can be found at:

Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148.www.mhra.gov.uk/yellowcard

For more information about Biquelle XL, please click here for the prescribing information.

Cost Saving

Up to 56% savings on the cost of category C quetiapine XL  prescriptions by prescribing Biquelle XL.2*

By prescribing Biquelle XL by brand, the average savings for a ICS/B could be more than £142,043 per year providing the NHS with a total potential annual prescribing cost saving of more than £8.7 million.**

Biquelle XL Cost Calculator

To find out how much you can save by prescribing Biquelle XL, please follow the instructions on the Biquelle XL calculator:

View the cost calculator

Biquelle XL is part of the cost-saving prolonged-release product range from Aspire Pharma.

  • Up to 56% savings on Category C Drug Tariff prices;
  • Available from mainline wholesalers;
  • High level of stockholdings;
  • Price guaranteed until 2024***
  • Bioequivalent to the originator.3
Biquelle XL Quetiapine prolonged- tablets Category C Drug Tariff price (pack size 60) 1 Biquelle XL Price
Pack size 60 Pack size 30
50mg £67.66 £29.45 £14.73
150mg £113.10 £49.45 £24.73
200mg £113.10 £49.45 £24.73
300mg £170.00 £74.45 £37.23
400mg £226.20 £98.95 £49.48
600mg The only 600mg prolonged-release quetiapine tablets (pack size 30), priced at: £70.73 per month
*Based on 56% saving when prescribing Biquelle XL 50, 150, 200, 300 and 400mg tablets only, versus the cost of Category C quetiapine XL on the UK Drug Tariffs. ** Annual cost saving based on modelled market quarterly turnover data x 4 surrounding 42 ICS/ICBS reviewing their generic quetiapine prolonged-release tablet prescriptions to Biquelle XL. ***No change in price subject to no material change to the products or Category C of the UK Drug Tariffs until the 2024 VPAS review.
References: 1) Insypher data: 10100831045 v 13.0 April 2023 CSC XL Range, GPPLPD Date Range: Sep-22 -Nov-22 MQT x4 2) UK Drug Tariffs (April 2023). 3) 1010067149 v 5.0 September 2021 Data on File – Bioequivalence for prolonged-release

More products available
in this range:
Click to view their
individual websites

BIQ1010269C1_APR2023